Impact of genetic polymorphisms and drug-drug interactions mediated by carboxylesterase 1 on remimazolam deactivation.

MLA

Wang, Zhuo, et al. “Impact of Genetic Polymorphisms and Drug-Drug Interactions Mediated by Carboxylesterase 1 on Remimazolam Deactivation.” Drug Metabolism and Disposition: The Biological Fate of Chemicals, vol. 53, no. 1, Jan. 2025, p. 100023. EBSCOhost, https://doi.org/10.1124/dmd.124.001916.

APA

Wang, Z., McCalla, Z., Lin, L., Tornichio, D., Agyemang, Y., Bastulli, J. A., Zhang, X. S., Zhu, H.-J., & Wang, X. (2025). Impact of genetic polymorphisms and drug-drug interactions mediated by carboxylesterase 1 on remimazolam deactivation. Drug Metabolism and Disposition: The Biological Fate of Chemicals, 53(1), 100023. https://doi.org/10.1124/dmd.124.001916

Chicago

Wang, Zhuo, Zachary McCalla, Li Lin, Dominic Tornichio, Yaw Agyemang, John A Bastulli, Xiaochun Susan Zhang, Hao-Jie Zhu, and Xinwen Wang. 2025. “Impact of Genetic Polymorphisms and Drug-Drug Interactions Mediated by Carboxylesterase 1 on Remimazolam Deactivation.” Drug Metabolism and Disposition: The Biological Fate of Chemicals 53 (1): 100023. doi:10.1124/dmd.124.001916.